Wird geladen...

Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells

Accumulating evidence suggests that metformin, a biguanide class of anti-diabetic drugs, possesses anti-cancer properties and may reduce cancer risk and improve prognosis. However, the mechanism by which metformin affects various cancers, including renal cancer still unknown. MiR-26a induces cell gr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Clin Exp Med
Hauptverfasser: Yang, Feng-Qiang, Wang, Ji-Jiao, Yan, Jia-Sheng, Huang, Jian-Hua, Li, Wei, Che, Jian-Ping, Wang, Guang-Chun, Liu, Min, Zheng, Jun-Hua
Format: Artigo
Sprache:Inglês
Veröffentlicht: e-Century Publishing Corporation 2014
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4238495/
https://ncbi.nlm.nih.gov/pubmed/25419360
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!